SCHEMBL12412264

SCHEMBL12412264

[C-]#[N+]c1cc2c(Oc3ccc(Cl)c(NC(=O)NC4CC4)c3)ccnc2cc1OCCN1CCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT1 P17948 5/20 0.53
FLT4 P35916 5/20 0.53
KDR P35968 5/20 0.53
FGFR4 P22455 13/20 0.51
FGFR1 P11362 3/20 0.51
FGFR2 P21802 3/20 0.51
FGFR3 P22607 3/20 0.51
RET P07949 2/20 0.51
KIT P10721 2/20 0.51
PDGFRA P16234 2/20 0.51
RIPK2 O43353 1/20 0.51
ERN1 O75460 1/20 0.51
STK10 O94804 1/20 0.51
MAP3K6 O95382 1/20 0.51
ABL1 P00519 1/20 0.51
ESR1 P03372 1/20 0.51
PDGFRB P09619 1/20 0.51
ADORA3 P0DMS8 1/20 0.51
BCR P11274 1/20 0.51
NQO2 P16083 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12412086 0.91 FLT1 (0.66) FLT1FLT4KDRFGFR4FGFR1
SCHEMBL12412415 0.90 FLT1 (0.65) FLT1FLT4KDRFGFR4FGFR1
SCHEMBL12412268 0.89 FGFR4 (0.48) FLT1FLT4KDRFGFR4FGFR1
SCHEMBL12412262 0.88 KDR (0.49) FLT1FLT4KDRPDGFRAMET
SCHEMBL12412263 0.87 KCNA5 (0.45) FLT1FLT4KDRRETKIT
SCHEMBL1889051 0.87 FLT1 (0.52) FLT1FLT4KDRFGFR4FGFR1
SCHEMBL12412346 0.86 KDR (0.55) FLT1FLT4KDRFGFR4FGFR1
SCHEMBL12412094 0.83 FGFR4 (0.55) FLT1FLT4KDRFGFR4FGFR1
SCHEMBL12412093 0.83 FGFR4 (0.55) FLT1FLT4KDRFGFR4FGFR1
SCHEMBL12412090 0.83 FGFR4 (0.58) FLT1FLT4KDRFGFR4FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8372981-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2013-02-12 US disclosed
US-7973160-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-07-05 US disclosed
US-20110118470-A1 NITROGEN-CONTAINING AROMATIC DERIVATIVES FUNAHASHI YASUHIRO 2011-05-19 US disclosed
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-05 US disclosed
US-7612092-B2 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed
US-7253286-B2 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI CO., LTD (JP) 2007-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives GNG2, GCG, FRG1 FLT1 1368/4885FLT4 3144/4885KDR 2687/4885
US-20110118470-A1 NITROGEN-CONTAINING AROMATIC DERIVATIVES GNG2, GCG, FRG1 FLT1 1346/4885FLT4 3139/4885KDR 2782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.